151 related articles for article (PubMed ID: 3005180)
1. Use of artificial liver support.
Williams R; Ede R; Hughes R
Int J Clin Pharmacol Res; 1985; 5(6):381-7. PubMed ID: 3005180
[TBL] [Abstract][Full Text] [Related]
2. Removal of inhibitors of brain Na+, K+-ATPase by hemoperfusion in fulminant hepatic failure.
Seda HW; Hughes RD; Gove CD; Williams R
Artif Organs; 1984 May; 8(2):174-8. PubMed ID: 6329147
[TBL] [Abstract][Full Text] [Related]
3. Experimental artificial liver support with emphasis on fulminant hepatic failure: concepts and review.
Chang TM
Semin Liver Dis; 1986 May; 6(2):148-58. PubMed ID: 3529408
[TBL] [Abstract][Full Text] [Related]
4. [New apparatus for artificial liver support: PAT resin--removal of protein-bound substances and its effect on hepatic failure in animals].
Omori Y
Nihon Geka Gakkai Zasshi; 1985 May; 86(5):566-75. PubMed ID: 4021990
[TBL] [Abstract][Full Text] [Related]
5. Earlier charcoal haemoperfusion in fulminant hepatic failure.
Gimson AE; Braude S; Mellon PJ; Canalese J; Williams R
Lancet; 1982 Sep; 2(8300):681-3. PubMed ID: 6126626
[TBL] [Abstract][Full Text] [Related]
6. Artificial liver: the effect of ACAC microencapsulated charcoal hemoperfusion on fulminant hepatic failure.
Chirito E; Reiter B; Lister C; Chang TM
Artif Organs; 1977 Aug; 1(1):76-83. PubMed ID: 616275
[TBL] [Abstract][Full Text] [Related]
7. Effects of serial resin hemoperfusion in fulminant hepatic failure.
Bihari D; Hughes RD; Gimson AE; Langley PG; Ede RJ; Eder G; Williams R
Int J Artif Organs; 1983 Nov; 6(6):299-302. PubMed ID: 6668092
[TBL] [Abstract][Full Text] [Related]
8. Prostacyclin to prevent platelet activation during charcoal haemoperfusion in fulminant hepatic failure.
Gimson AE; Langley PG; Hughes RD; Canalese J; Mellon PJ; Williams R; Woods HF; Weston MJ
Lancet; 1980 Jan; 1(8161):173-5. PubMed ID: 6101632
[TBL] [Abstract][Full Text] [Related]
9. Haemoperfusion through activated carbon adsorbents in liver failure and hepatic coma.
Bartels O
Acta Hepatogastroenterol (Stuttg); 1978 Aug; 25(4):324-9. PubMed ID: 696211
[No Abstract] [Full Text] [Related]
10. Biochemical, hematological and histological changes in a fulminant hepatic failure rat model for artificial liver assessment.
Chirito E; Lister C; Chang TM
Artif Organs; 1979 Feb; 3(1):42-6. PubMed ID: 435123
[TBL] [Abstract][Full Text] [Related]
11. Soluble liver extract as supplement to detoxification by hemoperfusion in liver failure.
Dixit V; Chang TM
Int J Artif Organs; 1981 Nov; 4(6):291-4. PubMed ID: 7333688
[TBL] [Abstract][Full Text] [Related]
12. Haemoperfusion through activated charcoal in dogs with fulminant liver failure.
Horák J; Horký J; Rábl M
Digestion; 1980; 20(1):22-30. PubMed ID: 7353731
[TBL] [Abstract][Full Text] [Related]
13. In vitro adsorption of possible aetiological factors of hepatic encephalopathy.
Chamuleau RA; Schoemaker LP; Smit EM
Int J Artif Organs; 1979 Nov; 2(6):284-8. PubMed ID: 389835
[TBL] [Abstract][Full Text] [Related]
14. Liver support systems: the low clearance of model hepatic excretory anions by charcoal hemoperfusion.
Hew JT; Hart FE; Willson RA
Gastroenterology; 1978 Apr; 74(4):661-3. PubMed ID: 631502
[TBL] [Abstract][Full Text] [Related]
15. Effects of hemoperfusion rate and time of initiation of ACAC charcoal hemoperfusion on the survival of fulminant hepatic failure rats.
Chang TM; Lister C; Chirito E; O'Keefe P; Resurreccion E
Trans Am Soc Artif Intern Organs; 1978; 24():243-5. PubMed ID: 716006
[No Abstract] [Full Text] [Related]
16. Use of sorbent columns and haemofiltration in fulminant hepatic failure.
Hughes RD; Williams R
Blood Purif; 1993; 11(3):163-9. PubMed ID: 8280438
[TBL] [Abstract][Full Text] [Related]
17. Reduced brain Na+, K+-ATPase activity in rats with galactosamine-induced hepatic failure: relationship to encephalopathy and cerebral oedema.
Ede RJ; Gove CD; Hughes RD; Marshall W; Williams R
Clin Sci (Lond); 1987 Mar; 72(3):365-71. PubMed ID: 3028700
[TBL] [Abstract][Full Text] [Related]
18. Clinical experience with charcoal and resin hemoperfusion.
Hughes R; Williams R
Semin Liver Dis; 1986 May; 6(2):164-73. PubMed ID: 3018936
[No Abstract] [Full Text] [Related]
19. Platelet function during haemoperfusion in acute liver failure.
Hughes RD; Lane DA; Cella G; Kakkar VV; Langley PG; Williams R
Int J Artif Organs; 1980 Jan; 3(1):30-4. PubMed ID: 6444397
[TBL] [Abstract][Full Text] [Related]
20. Removal of protein-bound substance in hepatic failure: polyetherurethane sheet embedded with powdered charcoal (UPC).
Kawanishi H; Tsuchiya T; Nishiki M; Sugiyama M; Ezaki H
Int J Artif Organs; 1984 Nov; 7(6):343-8. PubMed ID: 6526530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
